Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection.
Driscoll
M S
MS
Department of Dermatology, University of Texas Medical Branch, Galveston 77550, USA.
Tyring
S K
SK
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017291:Clarithromycin / Q000627:therapeutic use*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy*; D016926:Mycobacterium chelonae / Q000187:drug effects; D017192:Skin Diseases, Bacterial / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D017291:Clarithromycin